<dl id="u6ggu"></dl>
  • <sup id="u6ggu"><bdo id="u6ggu"></bdo></sup>
  • <li id="u6ggu"></li>
  • <li id="u6ggu"><ins id="u6ggu"><thead id="u6ggu"></thead></ins></li><div id="u6ggu"><s id="u6ggu"></s></div><sup id="u6ggu"><menu id="u6ggu"></menu></sup>
  • <sup id="u6ggu"><bdo id="u6ggu"></bdo></sup>
    <li id="u6ggu"><ins id="u6ggu"></ins></li>
    <dl id="u6ggu"></dl>
  • <div id="u6ggu"></div>
    <dl id="u6ggu"></dl>
    <li id="u6ggu"><s id="u6ggu"></s></li>
  • <li id="u6ggu"><s id="u6ggu"></s></li>
    <sup id="u6ggu"></sup>
    <li id="u6ggu"></li>
    <div id="u6ggu"><tr id="u6ggu"></tr></div>
  • <dl id="u6ggu"></dl>
    <div id="u6ggu"></div>
  • <div id="u6ggu"></div>
  • <sup id="u6ggu"><ins id="u6ggu"></ins></sup>
  • <li id="u6ggu"></li>
    <center id="u6ggu"><wbr id="u6ggu"></wbr></center>
    <sup id="u6ggu"></sup>
    a sign on the side of a road: Gilead Sciences in Foster City, Calif. A bipartisan investigation by U.S. senators finds that the makers of a breakthrough drug for hepatitis C infection put profits before patients in pricing the $1,000-per-pill cure.? Eric Risberg Gilead Sciences in Foster City, Calif. A bipartisan investigation by U.S. senators finds that the makers of a breakthrough drug for hepatitis C infection put profits before patients in pricing the $1,000-per-pill cure.

    Pharmaceutical giant Gilead Sciences engaged in a “long-running scheme” to block generic competition of its combination drug “cocktails” to treat HIV, a new California lawsuit filed on Monday alleges.

    Loading...

    Load Error

    The plaintiffs in the suit claim that Gilead’s actions caused the cost of the life-saving treatment to rise.

    The suit accuses Gilead, the nation’s leading drugmaker for HIV treatments, of violating antitrust laws and maintaining a monopoly on the market for the HIV treatment known as “combination antiretroviral therapy,” or cART.

    The complaint, filed in the U.S. District Court in San Francisco, names drugmakers Bristol-Myers Squibb and Johnson & Johnson subsidiary Janssen Pharmaceuticals as co-defendants in what the plaintiffs say was a scheme to extend patent protection for their drugs and charge “exorbitant, supracompetitive” prices for the drugs.

    The companies are accused of entering into a number of “collusive agreements” that dissuaded Bristol-Myers and Johnson & Johnson from competing with Gilead’s HIV treatment. The suit also alleges the drugmakers would block other companies from competing against Gilead’s treatment even after Gilead’s patents expired. Representatives for Bristol-Myers and Janssen said that they received the complaint and are reviewing it. Neither company offered additional comment.

    Combination drugs reduce the total number of medications a person with HIV has to take. The treatment reduces the levels of the HIV virus in the blood, helps reverse damage to the immune system and reduces the risk of AIDS-related illnesses. According to the suit, more than 80% of patients starting an HIV regimen in the United States take one or more of Gilead’s combination drugs every day.

    The company generates more than $11 billion in revenue yearly from sales of its HIV treatments.

    Along with driving up prices, the suit claims Gilead’s monopoly on the HIV treatment market stifled innovation, “causing tens of thousands of people living with HIV to needlessly suffer debilitating side effects from inferior products.”

    Gilead shares were unchanged after market closed Monday. The company did not immediately respond to CNBC’s request for comment.

    FOLLOW NBC OUT ON TWITTER, FACEBOOK & INSTAGRAM

    In this Dec. 16, 2014 file photo, a for sale by owner sign sits in front of a home in Richardson, Texas. Real estate data provider CoreLogic reports on November home prices on Tuesday, Jan. 6, 2015. (AP Photo/LM Otero, File) Next Story

    Home flipping hits 9-year high — that could foretell trouble

    Feedback

    Found the story interesting?

    Like us on Facebook to see similar stories


    Send MSN Feedback

    We appreciate your input!

    Please give an overall site rating:

    平特精版料图片2017
    <dl id="u6ggu"></dl>
  • <sup id="u6ggu"><bdo id="u6ggu"></bdo></sup>
  • <li id="u6ggu"></li>
  • <li id="u6ggu"><ins id="u6ggu"><thead id="u6ggu"></thead></ins></li><div id="u6ggu"><s id="u6ggu"></s></div><sup id="u6ggu"><menu id="u6ggu"></menu></sup>
  • <sup id="u6ggu"><bdo id="u6ggu"></bdo></sup>
    <li id="u6ggu"><ins id="u6ggu"></ins></li>
    <dl id="u6ggu"></dl>
  • <div id="u6ggu"></div>
    <dl id="u6ggu"></dl>
    <li id="u6ggu"><s id="u6ggu"></s></li>
  • <li id="u6ggu"><s id="u6ggu"></s></li>
    <sup id="u6ggu"></sup>
    <li id="u6ggu"></li>
    <div id="u6ggu"><tr id="u6ggu"></tr></div>
  • <dl id="u6ggu"></dl>
    <div id="u6ggu"></div>
  • <div id="u6ggu"></div>
  • <sup id="u6ggu"><ins id="u6ggu"></ins></sup>
  • <li id="u6ggu"></li>
    <center id="u6ggu"><wbr id="u6ggu"></wbr></center>
    <sup id="u6ggu"></sup>
    <dl id="u6ggu"></dl>
  • <sup id="u6ggu"><bdo id="u6ggu"></bdo></sup>
  • <li id="u6ggu"></li>
  • <li id="u6ggu"><ins id="u6ggu"><thead id="u6ggu"></thead></ins></li><div id="u6ggu"><s id="u6ggu"></s></div><sup id="u6ggu"><menu id="u6ggu"></menu></sup>
  • <sup id="u6ggu"><bdo id="u6ggu"></bdo></sup>
    <li id="u6ggu"><ins id="u6ggu"></ins></li>
    <dl id="u6ggu"></dl>
  • <div id="u6ggu"></div>
    <dl id="u6ggu"></dl>
    <li id="u6ggu"><s id="u6ggu"></s></li>
  • <li id="u6ggu"><s id="u6ggu"></s></li>
    <sup id="u6ggu"></sup>
    <li id="u6ggu"></li>
    <div id="u6ggu"><tr id="u6ggu"></tr></div>
  • <dl id="u6ggu"></dl>
    <div id="u6ggu"></div>
  • <div id="u6ggu"></div>
  • <sup id="u6ggu"><ins id="u6ggu"></ins></sup>
  • <li id="u6ggu"></li>
    <center id="u6ggu"><wbr id="u6ggu"></wbr></center>
    <sup id="u6ggu"></sup>
    大丰收援彩金 勇士vs国王第三节录像 开心假期电子游戏 天龙大哥大 富裕人生游戏 重庆时时彩开奖时间调整 天天分分彩开奖号码 封神演义2019在线观看 百慕大三角客服 亚洲风情四区 水晶裂谷游戏 北京赛车规律论坛 飞禽走兽多人版打法 好事成双客服 双彩排列三试机号 水果拉霸